InspireMD Inc. (AMEX:NSPR) headquartered in Tel Aviv, will host a conference call for the investment community to discuss the 3Q20 financial results on 9th November 2020 at 8:30 AM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.inspiremd.com
Earnings Expectation
InspireMD Inc. is set to announce third quarter earning results on Monday 9th November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, NSPR to report 3Q20 loss of $ 0.18 per share from revenue of $ 0.40 million. For the full year, analysts anticipate top line of $ 2.35 million, while looking forward to loss of $ 0.87 per share bottom line.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms.
